Murray Dallan 4
4 · Sarepta Therapeutics, Inc. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Murray Dallan
Chief Customer Officer
Transactions
- Award
Performance Restricted Stock Units
2025-02-11+3,500→ 17,500 total→ Common Stock (3,500 underlying)
Footnotes (1)
- [F1]Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.